GenXys provides the world’s most comprehensive precision prescribing software to solve healthcare’s most pressing challenges. Our precision prescribing software and pharmacogenetic solutions prevent adverse drug reactions, a leading cause of death in developed countries, and personalize drug selection to increase drug efficacy. Powering every prescription with our software improves medication safety, improves treatment response, and reduces healthcare costs.
Accountability – we hold ourselves and our teams accountable for high quality and timely deliverables
Consumer-centric – the customer is central to our decision making and all that we do
Quality – in everything, we innovate from an evidence-based bedrock
Urgency – we foster a dynamic environment and work with a sense of urgency, but not at the sake of accuracy or quality
Integrity – everything we do as individuals, as teams, and as a company collective is based on honesty, transparency, and doing the right thing at the right time
Teamwork – we work as high-functioning collaborative teams to challenge the status quo and deliver excellence in a dynamic environment
Mark Gelfer – MD
Chairman of the Board
Dr. Mark Gelfer has more than 20 years of experience with company creation as founder – CMO (VSM MedTech) and product development and commercialization (BpTRU). He is a family physician with a keen interest in innovation of clinical practices and over 30 years of medical experience. His practice is focused on preventive medicine.
Chief Executive Officer
Karl has an international background in healthcare at two multinational pharmaceutical companies and over 15 successful years of launching early-stage software companies and transforming their solutions into ‘best in class’ across diverse industries in the US and globally. He drinks way too much coffee during the week, so he balances it off by yacht racing and fly-fishing on the weekend.
Professor Martin Dawes is a world expert in primary care who combines research and clinical practice with over 30 years of experience. Following the completion of his PhD, he helped develop a Masters program in Evidence Based Health Care. He has directed the UK Centre for Evidence-Based Medicine in Oxford and was the head of family practice at McGill University and the University of British Columbia.
Gustavo Bernard Esquivel Zavala, MD, PhD, MHA
Chief Medical Officer
Bernard Esquivel is a practicing physician-scientist, senior executive, and international leader with in-depth expertise developing new markets, devising compelling value propositions, go-to-market strategies, and launching programs to fulfill organizational goals and objectives in the healthcare space. Notably, he mobilized a local healthcare community to engage in the practice of precision medicine by founding and presiding over the Latin American Association of Personalized Medicine (ALAMP). This organization now includes more than 500 members from nine countries in Latin America.
Independent Board Member
Ohad brings to GenXys a dynamic 20-year experience as an entrepreneur, public company executive and CEO in the digital health and medical device. In addition to his position as Director on the GenXys Board, he serves as the Entrepreneur In Residence for TELUS Ventures – the corporate venture capital arm of $16B giant TELUS – driving the fund’s international investments and the healthcare portfolio. Ohad is also the Chairman of the Board for big data platform vendor Genoox, and recently served as Chief Executive Officer for Zebra Medical Vision, an award winning, venture-back imaging AI company from Israel. Prior to his tenure at Zebra Med, Ohad served as the Chief Strategy Officer for TELUS Health and led the Provider Solutions Business Unit. In this capacity he grew the reach of the organization to deliver Electronical Medical Record systems to 28,000 primary care physicians in Canada and launch Canada’s first electronic prescribing network.
Diana Dawes – MSc, MCSP
Diana Dawes was one of the leading visionaries behind the establishment of GenXys. She has an MSc in Evidence-Based Health Care from Oxford and is a clinical associate professor at the University of British Columbia. Diana is a successful epidemiologist running clinical trials and synthesizing the best evidence.
Karen Boodram – MBA
Karen has over 25 years of experience in senior roles for both the pharmaceutical industry and capital markets, focusing on commercializing new and innovative health technologies.
Jillian Reardon – BSc. (Pharm), ACPR, PharmD, RPh
Dr. Reardon is a lecturer and pharmacist with the UBC Faculty of Pharmaceutical Sciences. She has an active primary care practice through the UBC Pharmacists Clinic with research interests in the areas of innovative pharmacy practice and clinical teaching.
Senior Instructor and Director, Community Pharmacy Residency, Faculty of Pharmaceutical Sciences at the University of British Columbia.